Evidence map›Paper›PMID 28591647›Full record

ReviewStem cell reports2017

The Art of Capturing Pluripotency: Creating the Right Culture.

Qi-Long Ying, Austin Smith

Abstract readReview
In one paragraph

Review in Stem cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Organization of the Pluripotent Genome.Cold Spring Harbor perspectives in biology · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. JAK/STAT signaling in stem cells and regeneration: fromDevelopment (Cambridge, England) · 2019
    Review
  15. Review
  16. Article
  17. Pluripotent Stem Cell Platforms for Drug Discovery.Trends in molecular medicine · 2018
    Review
  18. Article
  19. Capturing bovine pluripotency.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qi-Long YingEli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Electronic address: qying@med.usc.edu.
Austin SmithWellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK; Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1GA, UK. Electronic address: austin.smith@cscr.cam.ac.uk.

Funding

DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLSR01OD010926 · OD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YING, QILONG · 2012 to 2014
$1.2M
Medical Research Council G1100526Medical Research Council MR/P00072X/1NIH HHS R01 OD010926
6 · The paper itself

Abstract

Embryonic stem cells (ESCs) are a unique tool for genetic perturbation of mammalian cellular and organismal processes additionally in humans offer unprecedented opportunities for disease modeling and cell therapy. Furthermore, ESCs are a powerful system for exploring the fundamental biology of pluripotency. Indeed understanding the control of self-renewal and differentiation is key to realizing the potential of ESCs. Building on previous observations, we found that mouse ESCs can be derived and maintained with high efficiency through insulation from differentiation cues combined with consolidation of an innate cell proliferation program. This finding of a pluripotent ground state has led to conceptual and practical advances, including the establishment of germline-competent ESCs from recalcitrant mouse strains and for the first time from the rat. Here, we summarize historical and recent progress in defining the signaling environment that supports self-renewal. We compare the contrasting requirements of two types of pluripotent stem cell, naive ESCs and primed post-implantation epiblast stem cells (EpiSCs), and consider the outstanding challenge of generating naive pluripotent stem cells from different mammals.

Indexed as

AnimalsCell DifferentiationCell Self RenewalEmbryonic Stem CellsGlycogen Synthase Kinase 3HumansLeukemia Inhibitory FactorPluripotent Stem CellsSignal TransductionTranscription FactorsGlycogen Synthase Kinase 3Leukemia Inhibitory FactorTranscription Factorsembryonic stem cellepiblast stem cellERKLIF/Stat3MEKnaive pluripotencyprimed pluripotencystem cell differentiationstem cell self-renewalWnt/β-catenin

Identifiers

PMID28591647
PMCPMC5470336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.